| Date Filed | Type | Description |
| 01/19/2023 |
4
| KEATING LAURIE (Director) has filed a Form 4 on PepGen Inc.|
Txns:
| Bought 4,166 shares
@ $12, valued at
$50k
|
|
| 01/11/2023 |
4
| KEATING LAURIE (Director) has filed a Form 4 on Imago BioSciences, Inc.|
Txns:
| Disposed/sold 23,809 options to buy
@ $22.76, valued at
$541.9k
Disposed/sold 11,904 options to buy
@ $15.65, valued at
$186.3k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| KEATING LAURIE (Director) has filed a Form 4 on Imago BioSciences, Inc.|
Txns:
| Granted 11,904 options to buy
@ $15.65, valued at
$186.3k
|
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/19/2021 |
4
| KEATING LAURIE (Director) has filed a Form 4 on Imago BioSciences, Inc.|
Txns:
| Granted 23,809 options to buy
@ $22.76, valued at
$541.9k
|
|
| 11/19/2021 |
3
| KEATING LAURIE (Director) has filed a Form 3 on Imago BioSciences, Inc. |
| 08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2021 |
3
| KEATING LAURIE (Director) has filed a Form 3 on Immuneering Corp |
| 07/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2020 |
4
| KEATING LAURIE (EVP, Chief Legal Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 10,000 shares
@ $139, valued at
$1.4M
Exercised 10,000 options to buy
@ $77.4, valued at
$774k
|
|
| 04/09/2020 |
4
| KEATING LAURIE (EVP, Chief Legal Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 4,167 shares
@ $0
Paid exercise price by delivering 1,858 shares
@ $104.75, valued at
$194.6k
Paid exercise price by delivering 75 shares
@ $105.63, valued at
$7.9k
|
|
| 02/28/2020 |
4
| KEATING LAURIE (EVP, Chief Legal Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 24,554 options to buy
@ $118.05, valued at
$2.9M
|
|
| 02/12/2020 |
4
| KEATING LAURIE (EVP, Chief Legal Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 10,000 shares
@ $129, valued at
$1.3M
Exercised 10,000 options to buy
@ $77.4, valued at
$774k
|
|
| 02/12/2020 |
4/A
| KEATING LAURIE (EVP, Chief Legal Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Exercised 3,663 shares
@ $77.4, valued at
$283.5k
|
|
| 01/31/2020 |
4
| KEATING LAURIE (EVP, Chief Legal Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 6,337 shares
@ $119, valued at
$754.1k
Exercised 6,337 options to buy
@ $77.4, valued at
$490.5k
|
|
| 01/29/2020 |
4
| KEATING LAURIE (EVP, Chief Legal Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 3,365 shares
@ $115.55, valued at
$388.8k
Sold 13,631 shares
@ $116.43, valued at
$1.6M
Sold 4,100 shares
@ $117.67, valued at
$482.4k
Sold 13,084 shares
@ $118.61, valued at
$1.6M
Sold 6,667 shares
@ $119.53, valued at
$796.9k
Sold 190 shares
@ $120.21, valued at
$22.8k
Exercised 25,000 options to buy
@ $42.22, valued at
$1.1M
Exercised 9,374 options to buy
@ $42.22, valued at
$395.8k
Exercised 3,663 options to buy
@ $77.4, valued at
$283.5k
|
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/26/2019 |
4
| KEATING LAURIE (EVP, Chief Legal Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Acquired 10 shares
@ $0
Granted 4,583 options to buy
@ $119.13, valued at
$546k
|
|
| 08/07/2019 |
4
| KEATING LAURIE (EVP, Chief Legal Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Acquired 49 shares
@ $0
Granted 3,500 options to buy
@ $88.95, valued at
$311.3k
Granted 6,250 options to buy
@ $42.22, valued at
$263.9k
|
|
| 06/07/2019 |
4
| KEATING LAURIE (EVP, Chief Legal Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Acquired 14 shares
@ $0
Acquired 41 shares
@ $0
Granted 6,250 options to buy
@ $42.22, valued at
$263.9k
|
|
| 03/01/2019 |
4
| KEATING LAURIE (SVP, GC & Secretary) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 options to buy
@ $85, valued at
$2.1M
|
|
| 09/28/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2018 |
4
| KEATING LAURIE (SVP, GC & Secretary) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 3,500 options to buy
@ $88.95, valued at
$311.3k
|
|
|